Screener
BioCryst Pharmaceuticals BCRX Amortization of premium/discount on investments
Amortization of premium/discount on investments at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept bcrx:AmortizationOfPremiumDiscountOnInvestments.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Payment of Pharmakon paid-in-kind interest | — | (5,492) |
| Non-cash interest expense on royalty financing obligations | 26,330 | 26,916 |
| Amortization of debt issuance costs on term loans | 352 | 1,003 |
| Amortization of discount on investments, net | (166) | (2,533) |
| Loss on extinguishment of debt | — | 4,171 |
| Changes in operating assets and liabilities: | ||
| Increase in trade receivables | (1,959) | (21,295) |
| (Increase) decrease in inventory | (9,196) | 568 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's amortization of premium/discount on investments?
- BioCryst Pharmaceuticals (BCRX) reported amortization of premium/discount on investments of -$417K in Q2 2026.
- How has BioCryst Pharmaceuticals's amortization of premium/discount on investments changed year-over-year?
- BioCryst Pharmaceuticals's amortization of premium/discount on investments increased by 63.7% year-over-year, from -$1.15M to -$417K.
- What is the long-term trend for BioCryst Pharmaceuticals's amortization of premium/discount on investments?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's amortization of premium/discount on investments has grown at a 582.2% compound annual growth rate (CAGR), from -$2K to -$4.33M.
- What does amortization of premium/discount on investments mean?
- Amortization of premium/discount on investments as reported by BioCryst Pharmaceuticals Inc.
Ask your AI about BioCryst Pharmaceuticals's amortization of premium/discount on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude